Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px
Financing › Details

Harpoon Therapeutics–SEVERAL: investment, 201812– IPO $86m FILED

 

Period Period 2018-12-27
Region Region United States (USA)
  Predecessor Harpoon Therapeutics–SEVERAL: investment, 201811 financing round Series C $70m led by OrbiMed
Organisation Money taker Harpoon Therapeutics Inc.
Products Product TriTAC™ imunno-oncology platform (tri-specific T-cell activating construct immuno-oncology platform)
  Product 2 investment banking
     

   
Record changed: 2019-03-14

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for Harpoon Therapeutics Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top